Related references
Note: Only part of the references are listed.Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications
Yifei Wang et al.
ONCOGENE (2023)
The role of N-glycosylation modification in the pathogenesis of liver cancer
Mengyu Hu et al.
CELL DEATH & DISEASE (2023)
Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC- HCD-PRM-MS/MS
Yifei Tan et al.
ACS OMEGA (2023)
Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Prasanna Ramachandran et al.
JOURNAL OF PROTEOME RESEARCH (2022)
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
Yu Lin et al.
FRONTIERS IN ONCOLOGY (2022)
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
Yu Lin et al.
ACS OMEGA (2022)
Haptoglobin polymorphism affects its N-glycosylation pattern in serum
M. Kohansal-Nodehi et al.
JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB (2022)
Glycosylation in viral hepatitis
Ewa Gruszewska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
Cristian D. Gutierrez Reyes et al.
METABOLITES (2021)
Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study
Hiroomi Takayama et al.
BMC CANCER (2020)
N-Glycan profiling of lung adenocarcinoma in patients at different stages of disease
Erika Lattova et al.
MODERN PATHOLOGY (2020)
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease
Valentina Peta et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis
Jianhui Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2020)
A wealth of genotype-specific proteoforms fine-tunes hemoglobin scavenging by haptoglobin
Sem Tamara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma
Jonggi Choi et al.
HEPATOLOGY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics
Takashi Kobayashi et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
Pamela A. Norton et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS
Jianhui Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Sialic acids as cellular markers of immunomodulatory action of dexamethasone on glioma cells of different immunogenicity
Przemyslaw Wielgat et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
N-glycan microheterogeneity regulates interactions of plasma proteins
Di Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells
Tianhua Liu et al.
ONCOLOGY LETTERS (2017)
Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection
Tian Xiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Human plasma protein N-glycosylation
Florent Clerc et al.
GLYCOCONJUGATE JOURNAL (2016)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Insights on N-glycosylation of human haptoglobin and its association with cancers
Shu Zhang et al.
GLYCOBIOLOGY (2016)
Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs
Lei Cheng et al.
ONCOTARGET (2016)
Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
Hitomi Asazawa et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format
Jianhui Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Biomarkers for the early diagnosis of hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies
Jianhui Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer
Jung-Mo Ahn et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development
Dominik J. Schaer et al.
FRONTIERS IN PHYSIOLOGY (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Site-specific Glycoforms of Haptoglobin in Liver Cirrhosis and Hepatocellular Carcinoma
Petr Pompach et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
Ying Zhou et al.
BMC CANCER (2012)
Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue
Anand Mehta et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma
Sayo Kobayashi et al.
HEPATOLOGY RESEARCH (2012)
N-glycosylation of Colorectal Cancer Tissues
Crina I. A. Balog et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
High-Mannose Glycans are Elevated during Breast Cancer Progression
Maria Lorna A. de Leoz et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Haptoglobin: Basic and Clinical Aspects
Andrew P. Levy et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
N-Glycosylation Increases the Circulatory Half-Life of Human Growth Hormone
Thomas V. Flintegaard et al.
ENDOCRINOLOGY (2010)
Identification and Confirmation of Biomarkers Using an Integrated Platform for Quantitative Analysis of Glycoproteins and Their Glycosylations
Yashu Liu et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Detection of Hepatocellular Carcinoma Using Glycomic Analysis
Radoslav Goldman et al.
CLINICAL CANCER RESEARCH (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
Alejandro Forner et al.
GASTROENTEROLOGY (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts
Tsutomu Nakagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
An introduction to ROC analysis
Tom Fawcett
PATTERN RECOGNITION LETTERS (2006)
The hepatitis B virus x protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III
SK Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular viral oncology of hepatocellular carcinoma
TM Block et al.
ONCOGENE (2003)
Structure-function analysis of the antioxidant properties of haptoglobin
M Melamed-Frank et al.
BLOOD (2001)
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
D Li et al.
CLINICA CHIMICA ACTA (2001)
Ectopic expression of α1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase
W Wang et al.
GLYCOBIOLOGY (2001)
A simple generalisation of the area under the ROC curve for multiple class classification problems
DJ Hand et al.
MACHINE LEARNING (2001)
Haptoglobin, an inflammation-inducible plasma protein
YP Wang et al.
REDOX REPORT (2001)